Gabelli & CO Investment Advisers, Inc. Vor Biopharma Inc. Transaction History
Gabelli & CO Investment Advisers, Inc.
- $603 Million
- Q1 2025
A detailed history of Gabelli & CO Investment Advisers, Inc. transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Gabelli & CO Investment Advisers, Inc. holds 20,773 shares of VOR stock, worth $4,570. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,773
Previous 30,000
30.76%
Holding current value
$4,570
Previous $33,000
57.58%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding VOR
# of Institutions
45Shares Held
54.1MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA39.6MShares$8.72 Million0.59% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$1.4 Million3.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$426,8490.0% of portfolio
-
Johnson & Johnson New Brunswick, NJ1.07MShares$236,4240.26% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny701KShares$154,3140.0% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $8.37M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...